Trial Profile
Phase II trial of Bevacizumab with XELOX as an adjuvant treatment after resection of colorectal liver metastases
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Cancer metastases; Liver metastases
- Focus Therapeutic Use
- 16 May 2016 New trial record